Saudi Arabia Vaccines Market to 2032
Overview
The Saudi Arabia Vaccines Market is expected to reach a 719.09 USD Billion by 2032 and is projected to grow at a CAGR of 10.63% from 2025 to 2032.
Revenue, 2024 (USD Billion)
413.05
Forecast, 2032 (USD Billion)
719.09
CAGR, 2024 - 2032
10.63%
Report Coverage
Saudi Arabia
Saudi Arabia Vaccines Market 2018-2032 USD Billion
Saudi Arabia Vaccines Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 413.05 USD Billion
- Projected Market Size (2032): 719.09 USD Billion
- CAGR (2025-2032): 10.63%
Key Findings of Saudi Arabia Vaccines Market
- The Saudi Arabia Vaccines Market was valued at 413.05 USD Billion in 2024.
- The Saudi Arabia Vaccines Market is likely to grow at a CAGR of 10.63% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 378.14 USD Billion
- The fastest growing segment Influenza in Diseases Segment grew Fastest with a CAGR of 12.49% during the forecast period from 2024 to 2032.
Saudi Arabia Vaccines Market Scope
Saudi Arabia Vaccines Market Segmentation & Scope
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Route of Administration
- Nasal
- Oral
- Injectable
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Saudi Arabia Vaccines Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 413.05 USD Billion |
| Market Value in 2032 | 719.09 USD Billion |
| CAGR (2025-2032) | 10.63% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Kind,Type,Age of Administration,Composition,Diseases,Route of Administration,Distribution Channel,End User |
Regional Insights:
-
Leading Market (2024-2032): Saudi Arabia, leading in terms of revenue 413.05 USD Billion in 2024
- Key Country: Saudi Arabia, leading in terms of revenue with value of 413.05 USD Billion in 2024.
Segments and Scope
-
Saudi Arabia Vaccines Market to 2032, By Kind
- Routine Vaccine is the largest segment in Saudi Arabia Vaccines Market to 2032 with a revenue of 279.61 USD Billion in the year 2024.
- Recommended Vaccines is the Fastest growing segment in Saudi Arabia Vaccines Market to 2032 with a Growth rate of 10.16 % in forecast period 2025-2032.
-
Saudi Arabia Vaccines Market to 2032, By Type
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the largest segment in Saudi Arabia Vaccines Market to 2032 with a revenue of 164.27 USD Billion in the year 2024.
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the Fastest growing segment in Saudi Arabia Vaccines Market to 2032 with a Growth rate of 11.35 % in forecast period 2025-2032.
-
Saudi Arabia Vaccines Market to 2032, By Age of Administration
- Pediatric Vaccines is the largest segment in Saudi Arabia Vaccines Market to 2032 with a revenue of 242.34 USD Billion in the year 2024.
- Adult Vaccines is the Fastest growing segment in Saudi Arabia Vaccines Market to 2032 with a Growth rate of 10.39 % in forecast period 2025-2032.
-
Saudi Arabia Vaccines Market to 2032, By Composition
- Combination Vaccines is the largest segment in Saudi Arabia Vaccines Market to 2032 with a revenue of 316.98 USD Billion in the year 2024.
- Combination Vaccines is the Fastest growing segment in Saudi Arabia Vaccines Market to 2032 with a Growth rate of 10.92 % in forecast period 2025-2032.
-
Saudi Arabia Vaccines Market to 2032, By Diseases
- Pneumoccocal Disease is the largest segment in Saudi Arabia Vaccines Market to 2032 with a revenue of 67.93 USD Billion in the year 2024.
- Influenza is the Fastest growing segment in Saudi Arabia Vaccines Market to 2032 with a Growth rate of 11.95 % in forecast period 2025-2032.
-
Saudi Arabia Vaccines Market to 2032, By Route of Administration
- Injectable is the largest segment in Saudi Arabia Vaccines Market to 2032 with a revenue of 378.14 USD Billion in the year 2024.
- Injectable is the Fastest growing segment in Saudi Arabia Vaccines Market to 2032 with a Growth rate of 10.68 % in forecast period 2025-2032.
-
Saudi Arabia Vaccines Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Saudi Arabia Vaccines Market to 2032 with a revenue of 279.54 USD Billion in the year 2024.
- Retail Pharmacy is the Fastest growing segment in Saudi Arabia Vaccines Market to 2032 with a Growth rate of 10.13 % in forecast period 2025-2032.
-
Saudi Arabia Vaccines Market to 2032, By End User
- Community Hospitals is the largest segment in Saudi Arabia Vaccines Market to 2032 with a revenue of 262.12 USD Billion in the year 2024.
- Specialty Centres is the Fastest growing segment in Saudi Arabia Vaccines Market to 2032 with a Growth rate of 10.40 % in forecast period 2025-2032.
Saudi Arabia Vaccines Market Company Share Analysis
Saudi Arabia Vaccines Market Geographical Sales Distribution, 2018-2032 USD Billion
Saudi Arabia Vaccines Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Saudi Arabia Vaccines Market is segmented based on Segmentation Kind,Type,Age of Administration,Composition,Diseases,Route of Administration,Distribution Channel,End User.
Saudi Arabia Vaccines Market was valued at USD 413.05(Revenue in USD Billion) in 2020.
Saudi Arabia Vaccines Market is projected to grow at a CAGR of 10.63% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Saudi Arabia Vaccines Market, holding a largest market share of 378.14 USD Billion in 2024
Coming Soon....
Saudi Arabia Vaccines Market Scope
Saudi Arabia Vaccines Market Segmentation & Scope
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Route of Administration
- Nasal
- Oral
- Injectable
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Frequently Asked Questions
The Saudi Arabia Vaccines Market is segmented based on Segmentation Kind,Type,Age of Administration,Composition,Diseases,Route of Administration,Distribution Channel,End User.
Saudi Arabia Vaccines Market was valued at USD 413.05(Revenue in USD Billion) in 2020.
Saudi Arabia Vaccines Market is projected to grow at a CAGR of 10.63% during the forecast period of 2024 to 2032.
The estimated market value of the Saudi Arabia Vaccines Market for final year is USD 719.09 (USD Billion).
Saudi Arabia Vaccines Market Company Profiling
Frequently Asked Questions
The Saudi Arabia Vaccines Market is segmented based on Segmentation Kind,Type,Age of Administration,Composition,Diseases,Route of Administration,Distribution Channel,End User.
Saudi Arabia Vaccines Market was valued at USD 413.05(Revenue in USD Billion) in 2020.
Saudi Arabia Vaccines Market is projected to grow at a CAGR of 10.63% during the forecast period of 2024 to 2032.
The estimated market value of the Saudi Arabia Vaccines Market for final year is USD 719.09 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.